[nanoPost] Pulmonary Nanoparticle Delivery

Company Australia

We are developing a process using Surface Acoustic Waves (SAW) for production and delivery of nanoparticulate large molecule drugs via inhalation.  The technology provides for precise particle-size control, and is encapsulated in a portable personal inhaler.  Initial developments use insulin as the benchmark.

There has been growing interest in the potential for the systematic delivery of drugs and therapeutic agents (e.g. peptides and proteins) via pulmonary (inhalation) means.  Pulmonary drug delivery is an attractive option compared to oral administration or other invasive delivery techniques. 

Applications include the delivery of insulin, erythropoietin, or for use in gene therapy for Cystic Fybrosis.  The SAW technique allows well-controlled generation of nanoparticles , and has potential for these applications.

Access the contact details for this post by subscribing to premium content membership. For more details on premium content membership see our membership and fees page >> or contact info@nanoposts.com.